• 1
    Schroder, K. and Tschopp, J., The inflammasomes. Cell 2010. 140: 821832.
  • 2
    Davis, B. K., Wen, H. and Ting, J. P.-Y., The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 2011. 29: 707735.
  • 3
    Dinarello, C. A., A clinical perspective of interleukin-1β as the gatekeeper of inflammation Eur. J. Immunol. 2011. 41: 12031217.
  • 4
    Schroder, K., Zhou, R. and Tschopp, J., The NLRP3 inflammasome: a sensor for metabolic danger? Science 2010. 327: 296300.
  • 5
    Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A. and Latz, E., Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008. 9: 847856.
  • 6
    Dostert, C., Petrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T. and Tschopp, J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008. 320: 674677.
  • 7
    Newman, Z. L., Leppla, S. H. and Moayeri, M., CA-074Me protection against anthrax lethal toxin. Infect. Immun. 2009. 77: 43274336.
  • 8
    Pétrilli, V., Papin, S., Dostert, C., Mayor, A., Martinon, F. and Tschopp, J., Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 2007. 14: 15831589.
  • 9
    Sato, T., Machida, T., Takahashi, S., Iyama, S., Sato, Y., Kuribayashi, K., Takada, K. et al., Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J. Immunol. 2004. 173: 285296.
  • 10
    Latz, E., NOX-free inflammasome activation. Blood 2010. 116: 13931394.
  • 11
    Nakahira, K., Haspel, J. A., Rathinam, V. A., Lee, S. J., Dolinay, T., Lam, H. C., Englert, J. A. et al., Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011. 12: 222230.
  • 12
    Zhou, R., Yazdi, A. S., Menu, P. and Tschopp, J., A role for mitochondria in NLRP3 inflammasome activation. Nature 2010. 469: 221225.
  • 13
    Colombini, M., VDAC: the channel at the interface between mitochondria and the cytosol. Mol. Cell. Biochem. 2004. 256–257: 107115.
  • 14
    Hayashi, T., Rizzuto, R., Hajnoczky, G. and Su, T. P., MAM: more than just a housekeeper. Trends Cell Biol. 2009. 19: 8188.
  • 15
    Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W. and Sheu, S. S., Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 2004. 287: C817C833.
  • 16
    Zhang, J. and Ney, P. A., Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 2009. 16: 939946.
  • 17
    Riedl, S. J. and Salvesen, G. S., The apoptosome: signalling platform of cell death. Nat. Rev. Mol. Cell Biol. 2007. 8: 405413.
  • 18
    Zhou, R., Tardivel, A., Thorens, B., Choi, I. and Tschopp, J., Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010. 11: 136140.
  • 19
    Saxena, G., Chen, J. and Shalev, A., Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J. Biol. Chem. 2010. 285: 39974005.
  • 20
    Shalev, A., Lack of TXNIP protects beta-cells against glucotoxicity. Biochem. Soc. Trans. 2008. 36: 963965.
  • 21
    Perregaux, D. and Gabel, C. A., Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 1994. 269: 1519515203.
  • 22
    Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P. et al., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006. 440: 228232.
  • 23
    Muruve, D. A., Petrilli, V., Zaiss, A. K., White, L. R., Clark, S. A., Ross, P. J., Parks, R. J. and Tschopp, J., The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008. 452: 103107.
  • 24
    Lamkanfi, M., Mueller, J. L., Vitari, A. C., Misaghi, S., Fedorova, A., Deshayes, K., Lee, W. P. et al., Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J. Cell Biol. 2009. 187: 6170.
  • 25
    Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C. et al., Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat. Immunol. 2010. 11: 897904.
  • 26
    Cain, K., Langlais, C., Sun, X. M., Brown, D. G. and Cohen, G. M., Physiological concentrations of K+inhibit cytochrome c-dependent formation of the apoptosome. J. Biol. Chem. 2001. 276: 4198541990.
  • 27
    Heinen, A., Camara, A. K. S., Aldakkak, M., Rhodes, S. S., Riess, M. L. and Stowe, D. F., Mitochondrial Ca2+-induced K+influx increases respiration and enhances ROS production while maintaining membrane potential. Am. J. Physiol. Cell Physiol. 2007. 292: C148C156.
  • 28
    Minn, A. H., Hafele, C. and Shalev, A., Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Endocrinology 2005. 146: 23972405.
  • 29
    Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R. et al., TXNIP regulates peripheral glucose metabolism in humans. PLoS Med. 2007. 4: e158.
  • 30
    Hui, S. T., Andres, A. M., Miller, A. K., Spann, N. J., Potter, D. W., Post, N. M., Chen, A. Z. et al., Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc. Natl. Acad. Sci. USA 2008. 105: 39213926.
  • 31
    Oka, S., Yoshihara, E., Bizen-Abe, A., Liu, W., Watanabe, M., Yodoi, J. and Masutani, H., Thioredoxin binding protein-2/thioredoxin-interacting protein is a critical regulator of insulin secretion and peroxisome proliferator-activated receptor function. Endocrinology 2009. 150: 12251234.
  • 32
    Stienstra, R., Joosten, L. A., Koenen, T., van Tits, B., van Diepen, J. A., van den Berg, S. A., Rensen, P. C. et al., The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 2010. 12: 593605.
  • 33
    Vandanmagsar, B., Youm, Y. H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E. et al., The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011. 17: 179188.
  • 34
    Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N. et al., Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 2002. 110: 851860.
  • 35
    Shao, W., Yeretssian, G., Doiron, K., Hussain, S. N. and Saleh, M., The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem. 2007. 282: 3632136329.
  • 36
    Neustadt, J. and Pieczenik, S. R., Medication-induced mitochondrial damage and disease. Mol. Nutr. Food Res. 2008. 52: 780788.
  • 37
    Cho, J. H., The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 2008. 8: 458466.
  • 38
    Maeda, S., Hsu, L. C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L. and Karin, M., Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005. 307: 734738.
  • 39
    Ishikura, T., Kanai, T., Uraushihara, K., Iiyama, R., Makita, S., Totsuka, T., Yamazaki, M. et al., Interleukin-18 overproduction exacerbates the development of colitis with markedly infiltrated macrophages in interleukin-18 transgenic mice. J. Gastroenterol. Hepatol. 2003. 18: 960969.
  • 40
    Dupaul-Chicoine, J., Yeretssian, G., Doiron, K., Bergstrom, K. S. B., McIntire, C. R., LeBlanc, P. M., Meunier, C. et al., Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 2010. 32: 367378.
  • 41
    Zaki, M. H., Boyd, K. L., Vogel, P., Kastan, M. B., Lamkanfi, M., Kanneganti, T. D., The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010. 32: 379391.
  • 42
    Roberts, R. L., Topless, R. K. G., Phipps-Green, A. J., Gearry, R. B., Barclay, M. L. and Merriman, T. R., Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease. Genes Immun. 2010. 11: 351356.
  • 43
    Schoultz, I., Verma, D., Halfvarsson, J., Törkvist, L., Fredrikson, M., Sjöqvist, U., Lördal, M. et al., Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am. J. Gastroenterol. 2009. 104: 11801188.
  • 44
    Travassos, L., Carneiro, L., Ramjeet, M., Hussey, S., Kim, Y., Magalhães, J., Yuan, L. et al., Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 2009. 11: 5562.
  • 45
    Saitoh, T., Fujita, N., Jang, M. H., Uematsu, S., Yang, B.-G., Satoh, T., Omori, H. et al., Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008. 456: 264268.
  • 46
    Schapira, A. H., Mitochondrial dysfunction in Parkinson's disease. Cell Death Differ. 2007. 14: 12611266.
  • 47
    Pott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I. and Pitossi, F. J., Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 2008. 131: 18801894.
  • 48
    Yi, P.-L., Tsai, C.-H., Lu, M.-K., Liu, H.-J., Chen, Y.-C. and Chang, F.-C., Interleukin-1beta mediates sleep alteration in rats with rotenone-induced parkinsonism. Sleep 2007. 30: 413425.
  • 49
    Lowell, B. B. and Shulman, G. I., Mitochondrial dysfunction and type 2 diabetes. Science 2005. 307: 384387.
  • 50
    Luft, R., The development of mitochondrial medicine. Proc. Natl. Acad. Sci. USA 1994. 91: 87318738.
  • 51
    Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T. and Donath, M. Y., Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl. J. Med. 2007. 356: 15171526.
  • 52
    Allen, I. C., Scull, M. A., Moore, C. B., Holl, E. K., McElvania-TeKippe, E., Taxman, D. J., Guthrie, E. H. et al., The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009. 30: 556565.
  • 53
    Ichinohe, T., Pang, I. K. and Iwasaki, A., Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 2010. 11: 404410.
  • 54
    Ilyinskii, P. O., Gabai, V. L., Sunyaev, S. R., Thoidis, G. and Shneider, A. M., Toxicity of influenza A virus matrix protein 2 for mammalian cells is associated with its intrinsic proton-channeling activity. Cell Cycle 2007. 6: 20432047.